Overview

Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis

Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of Flucanzol versus L-mesitran in the treatment of patients with recurrent vulvovaginal candidiasis. The investigator will look at vaginal swabs after 1, 6 and 12 months. The investigator included 252 patients.
Phase:
Phase 4
Details
Lead Sponsor:
Maastricht University Medical Center
Treatments:
Fluconazole